{"id":223,"date":"2024-05-20T16:19:46","date_gmt":"2024-05-20T08:19:46","guid":{"rendered":"https:\/\/cytoarm.com\/?page_id=223"},"modified":"2025-08-22T14:39:26","modified_gmt":"2025-08-22T06:39:26","slug":"pipeline","status":"publish","type":"page","link":"https:\/\/cytoarm.com\/zh\/pipeline\/","title":{"rendered":"\u8cfd\u6602\u7522\u7dda"},"content":{"rendered":"
<\/div>\n

\u8cfd\u6602\u7522\u7dda<\/strong><\/h1>\n\n\n\n
\"Line\"<\/div>\n<\/div>\n\n\n\n
\n

Armed-T\u2122 Platform could develop more than 50 types of therapies<\/h2>\n\n\n\n

Unlocking Limitless Potential with CytoArm’s Armed-T<\/strong><\/mark>\u2122<\/mark><\/strong> Platform<\/h5>\n\n\n\n
Our Armed-T<\/strong><\/mark>\u2122<\/mark><\/strong> pipeline features a range of therapies that are in various stages of development,
Reflecting our Armed-T\u2122<\/mark><\/strong> Platform could develop limitless innovative treatments to patients in need.<\/h6>\n<\/div>\n\n\n\n
\n
\"CytoArm\u2019s<\/div>\n\n\n\n
CTA-002\uff1a\u8f49\u79fb\u6027\u7d50\u76f4\u8178\u764c [\u9ede\u64ca\u89c0\u770bYouTube\u5f71\u7247]<\/a>\ud83d\udc48
\u6211\u5011\u7684\u6307\u6a19\u7522\u54c1 CTA-002<\/strong>, features EGFR Armed-T\u2122 <\/strong>cells designed to treat metastatic colorectal cancer by targeting the EGFR receptor. This therapy is currently under IND application in both Singapore and the U.S. CTA-002<\/strong> \u6709\u671b\u6210\u70ba EGFR \u8868\u9054\u5be6\u9ad4\u816b\u7624\u60a3\u8005\u7684\u7a81\u7834\u6027\u6cbb\u7642\u9078\u64c7\uff0c\u986f\u8457\u63d0\u9ad8\u5b58\u6d3b\u7387\u4e26\u6539\u5584\u751f\u6d3b\u54c1\u8cea\u3002\u672a\u4f86\u64f4\u5c55\u53ef\u80fd\u5305\u62ec\u5176\u4ed6 EGFR \u8868\u9054\u7684\u764c\u75c7\uff0c\u4f8b\u5982 (\u4e09\u9670\u6027\u4e73\u817a\u764c Click to watch videos on YouTube<\/a>)\ud83d\udc48.<\/h6>\n\n\n\n
CTA-003\uff1a\u524d\u5217\u817a\u817a\u764c
CTA-03 involves the development of PSMA Armed-T<\/strong>\u2122 cells targeting prostate adenocarcinoma, one of the most prevalent cancers among men. Now in the discovery phase, our research is focused on optimizing this therapy’s design and evaluating its therapeutic potential to meet the critical needs in prostate cancer treatment.<\/h6>\n\n\n\n
CTA-004\uff1a\u8f49\u79fb\u6027\u4e73\u817a\u764c
CTA-04 leverages HER-2 Armed-T<\/strong>\u2122 cells in the fight against metastatic breast carcinoma, an aggressive and challenging cancer type. Our ongoing research aims to create a treatment that not only manages but potentially reduces the spread of metastatic breast cancer, bringing renewed hope to patients with this condition.<\/h6>\n<\/div>\n\n\n\n
\n

\u8cfd\u6602\u5408\u4f5c\u958b\u767c\u7522\u7dda<\/h3>\n\n\n\n
\"CytoArm\u2019s<\/div>\n\n\n\n
CTA-001\uff1aB\u7d30\u80de\u767d\u8840\u75c5
CTA-001<\/strong> employs CD-19 Armed-T<\/strong>\u2122 cells and is being co-developed with SL-LINK company. Currently in the pre-clinical stage, this therapy is designed to target and eliminate malignant B-cells in B-cell leukemia.
\u2192 Please see the NEWS\uff1aCytoArm Licenses CD19 Armed-T\u2122 <\/strong>cell for Blood Cancer Drug Development to SL-LINK Company<\/a><\/h6>\n\n\n\n
CTA-006\uff1a\u5fa9\u767c\/\u96e3\u6cbb\u6027\u5be6\u9ad4\u7624
CTA-006<\/strong> \u662f\u53e6\u4e00\u9805\u8207\u8ffd\u65e5\u6f64\u516c\u53f8\u806f\u5408\u958b\u767c\u7684\u5275\u65b0\u7642\u6cd5\uff0c\u5c08\u9580\u7528\u65bc\u61c9\u5c0d\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u5be6\u9ad4\u7624\u7684\u6311\u6230<\/h6>\n<\/div>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_gspb_post_css":".gspb_container-id-gsbp-0cdc137,.gspb_container-id-gsbp-64ffa17,.gspb_container-id-gsbp-f484abc,.gspb_container-id-gsbp-f7f41a2{flex-direction:column;box-sizing:border-box}#gspb_container-id-gsbp-0cdc137.gspb_container>p:last-of-type,#gspb_container-id-gsbp-64ffa17.gspb_container>p:last-of-type,#gspb_container-id-gsbp-f484abc.gspb_container>p:last-of-type,#gspb_container-id-gsbp-f7f41a2.gspb_container>p:last-of-type{margin-bottom:0}#gspb_container-id-gsbp-f7f41a2.gspb_container{position:relative;display:flex;flex-direction:column;justify-content:flex-end;align-items:center;margin-bottom:0;padding-top:100px;padding-bottom:160px}@media (max-width:575.98px){#gspb_container-id-gsbp-f7f41a2.gspb_container{margin-bottom:40px;padding-top:60px;padding-bottom:80px}}#gspb_container-id-gsbp-f7f41a2.gspb_container{background-size:cover;background-repeat:no-repeat;background-position:100% 50%;background-image:url(https:\/\/cytoarm.com\/wp-content\/uploads\/2024\/05\/scimgw8m9oowQezh6.webp)}#gspb_container-id-gsbp-f7f41a2.gspb_container:hover{background-size:cover}#gspb_container-id-gsbp-f7f41a2.gspb_container>.gspb_backgroundOverlay{transition:transform .5s cubic-bezier(.42,0,.58,1),opacity .5s ease,clip-path .5s ease;transform:scale(1) rotate(0deg) translateX(0) translateY(0);will-change:transform,opacity,clip-path;background-size:cover;background-repeat:no-repeat;background-position:81% 59%}body.gspb-bodyfront #gspb_container-id-gsbp-f7f41a2.gspb_container:hover>.gspb_backgroundOverlay{transform:scale(2.23) rotate(0deg) translateX(0) translateY(0)}#gspb_heading-id-gsbp-0cfd474{font-size:40px}@media (max-width:575.98px){#gspb_heading-id-gsbp-0cfd474{font-size:40px}}#gspb_heading-id-gsbp-0cfd474,#gspb_heading-id-gsbp-0cfd474 .gsap-g-line{text-align:center!important}#gspb_heading-id-gsbp-0cfd474{font-weight:400!important;color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:0;margin-bottom:0}#gspb_image-id-gsbp-830c1ad img{vertical-align:top;display:inline-block;box-sizing:border-box;max-width:100%;height:auto}#gspb_container-id-gsbp-0cdc137.gspb_container{position:relative;margin-top:-80px;margin-bottom:30px;padding-top:100px}@media (max-width:575.98px){#gspb_container-id-gsbp-0cdc137.gspb_container{padding-top:60px;padding-right:16px;padding-left:16px}}#gspb_container-id-gsbp-0cdc137.gspb_container,#gspb_container-id-gsbp-0cdc137.gspb_container>.gspb_backgroundOverlay{border-top-left-radius:32px;border-top-right-radius:32px}#gspb_container-id-gsbp-0cdc137.gspb_container{background-color:var(--wp--preset--color--palette-color-8, var(--theme-palette-color-8, #ffffff))}#gspb_heading-id-gsbp-6b5edee{transition-duration:.8s;transition-timing-function:var(--gs-root-animation-easing, cubic-bezier(0.42, 0, 0.58, 1));opacity:var(--gs-root-animation-opacity, 0);transition-property:opacity,transform,filter;transform:var(--gs-root-animation-transform, translate3d(0, calc(max(50px, 15%)), 0))}#gspb_heading-id-gsbp-6b5edee.aos-animate,#gspb_heading-id-gsbp-6b5edee[data-gs-aos]{opacity:1;transform:translateZ(0)}@media (max-width:575.98px){#gspb_heading-id-gsbp-6b5edee{font-size:30px}}#gspb_heading-id-gsbp-6b5edee,#gspb_heading-id-gsbp-6b5edee .gsap-g-line{text-align:center!important}#gspb_heading-id-gsbp-6b5edee{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:0;margin-bottom:24px}#gspb_heading-id-gsbp-3bc8408{transition-duration:.8s;transition-timing-function:var(--gs-root-animation-easing, cubic-bezier(0.42, 0, 0.58, 1));opacity:var(--gs-root-animation-opacity, 0);transition-property:opacity,transform,filter;transform:var(--gs-root-animation-transform, translate3d(0, calc(max(50px, 15%)), 0))}#gspb_heading-id-gsbp-3bc8408.aos-animate,#gspb_heading-id-gsbp-3bc8408[data-gs-aos]{opacity:1;transform:translateZ(0)}@media (max-width:575.98px){#gspb_heading-id-gsbp-3bc8408{font-size:24px}}#gspb_heading-id-gsbp-3bc8408,#gspb_heading-id-gsbp-3bc8408 .gsap-g-line{text-align:center!important}#gspb_heading-id-gsbp-3bc8408{margin-top:0;margin-bottom:0}@media (max-width:575.98px){#gspb_heading-id-gsbp-3bc8408{margin-top:24px}}#gspb_heading-id-gsbp-9f771e1{transition-duration:.8s;transition-timing-function:var(--gs-root-animation-easing, cubic-bezier(0.42, 0, 0.58, 1));opacity:var(--gs-root-animation-opacity, 0);transition-property:opacity,transform,filter;transform:var(--gs-root-animation-transform, translate3d(0, calc(max(50px, 15%)), 0))}#gspb_heading-id-gsbp-9f771e1.aos-animate,#gspb_heading-id-gsbp-9f771e1[data-gs-aos],#gspb_image-id-gsbp-5cda3a0 img.aos-animate,#gspb_image-id-gsbp-5cda3a0 img[data-gs-aos]{opacity:1;transform:translateZ(0)}@media (max-width:575.98px){#gspb_heading-id-gsbp-9f771e1{font-size:24px}}#gspb_heading-id-gsbp-9f771e1,#gspb_heading-id-gsbp-9f771e1 .gsap-g-line{text-align:center!important}#gspb_heading-id-gsbp-9f771e1{margin-top:0;margin-bottom:0}@media (max-width:575.98px){#gspb_heading-id-gsbp-9f771e1{margin-top:24px}}#gspb_container-id-gsbp-f484abc.gspb_container{position:relative;margin-top:0;margin-bottom:0}#gspb_heading-id-gsbp-d5d71da,#gspb_image-id-gsbp-5cda3a0 img{transition-duration:.8s;transition-timing-function:var(--gs-root-animation-easing, cubic-bezier(0.42, 0, 0.58, 1));opacity:var(--gs-root-animation-opacity, 0);transition-property:opacity,transform,filter}#gspb_heading-id-gsbp-d5d71da{transform:var(--gs-root-animation-transform, translate3d(0, calc(max(50px, 15%) * -1), 0))}#gspb_heading-id-gsbp-d5d71da.aos-animate,#gspb_heading-id-gsbp-d5d71da[data-gs-aos]{opacity:1;transform:translateZ(0)}#gspb_heading-id-gsbp-d5d71da,#gspb_heading-id-gsbp-d5d71da .gsap-g-line{text-align:left!important}#gspb_heading-id-gsbp-d5d71da{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:40px;margin-bottom:24px}#gspb_heading-id-gsbp-7f315da{transition-duration:.8s;transition-timing-function:var(--gs-root-animation-easing, cubic-bezier(0.42, 0, 0.58, 1));opacity:var(--gs-root-animation-opacity, 0);transition-property:opacity,transform,filter;transform:var(--gs-root-animation-transform, translate3d(0, calc(max(50px, 15%) * -1), 0))}#gspb_heading-id-gsbp-7f315da.aos-animate,#gspb_heading-id-gsbp-7f315da[data-gs-aos]{opacity:1;transform:translateZ(0)}#gspb_heading-id-gsbp-7f315da,#gspb_heading-id-gsbp-7f315da .gsap-g-line{text-align:left!important}#gspb_heading-id-gsbp-7f315da{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:0;margin-bottom:24px}#gspb_heading-id-gsbp-f54bfe3{transition-duration:.8s;transition-timing-function:var(--gs-root-animation-easing, cubic-bezier(0.42, 0, 0.58, 1));opacity:var(--gs-root-animation-opacity, 0);transition-property:opacity,transform,filter;transform:var(--gs-root-animation-transform, translate3d(0, calc(max(50px, 15%) * -1), 0))}#gspb_heading-id-gsbp-f54bfe3.aos-animate,#gspb_heading-id-gsbp-f54bfe3[data-gs-aos],#gspb_image-id-gsbp-623185a img.aos-animate,#gspb_image-id-gsbp-623185a img[data-gs-aos]{opacity:1;transform:translateZ(0)}#gspb_heading-id-gsbp-f54bfe3,#gspb_heading-id-gsbp-f54bfe3 .gsap-g-line{text-align:left!important}#gspb_heading-id-gsbp-f54bfe3{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:0;margin-bottom:24px}#gspb_container-id-gsbp-64ffa17.gspb_container{position:relative;margin-top:0;margin-bottom:30px}#gspb_image-id-gsbp-5cda3a0 img,#gspb_image-id-gsbp-623185a img{vertical-align:top;display:inline-block;box-sizing:border-box;max-width:100%;height:auto;transform:var(--gs-root-animation-transform, translate3d(0, calc(max(50px, 15%)), 0))}#gspb_image-id-gsbp-623185a{margin-bottom:0}#gspb_heading-id-gsbp-a496a07,#gspb_image-id-gsbp-623185a img{transition-duration:.8s;transition-timing-function:var(--gs-root-animation-easing, cubic-bezier(0.42, 0, 0.58, 1));opacity:var(--gs-root-animation-opacity, 0);transition-property:opacity,transform,filter}#gspb_heading-id-gsbp-a496a07{transform:var(--gs-root-animation-transform, translate3d(0, calc(max(50px, 15%) * -1), 0))}#gspb_heading-id-gsbp-a496a07.aos-animate,#gspb_heading-id-gsbp-a496a07[data-gs-aos]{opacity:1;transform:translateZ(0)}#gspb_heading-id-gsbp-a496a07,#gspb_heading-id-gsbp-a496a07 .gsap-g-line{text-align:left!important}#gspb_heading-id-gsbp-a496a07{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:32px;margin-bottom:24px}#gspb_heading-id-gsbp-6b60301{transition-duration:.8s;transition-timing-function:var(--gs-root-animation-easing, cubic-bezier(0.42, 0, 0.58, 1));opacity:var(--gs-root-animation-opacity, 0);transition-property:opacity,transform,filter;transform:var(--gs-root-animation-transform, translate3d(0, calc(max(50px, 15%) * -1), 0))}#gspb_heading-id-gsbp-6b60301.aos-animate,#gspb_heading-id-gsbp-6b60301[data-gs-aos]{opacity:1;transform:translateZ(0)}#gspb_heading-id-gsbp-6b60301,#gspb_heading-id-gsbp-6b60301 .gsap-g-line{text-align:left!important}#gspb_heading-id-gsbp-6b60301{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:0;margin-bottom:0}","footnotes":""},"class_list":["post-223","page","type-page","status-publish","hentry"],"blocksy_meta":{"has_hero_section":"disabled","styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":6},"content_style_source":"inherit","vertical_spacing_source":"custom","content_area_spacing":"bottom"},"_links":{"self":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/pages\/223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/comments?post=223"}],"version-history":[{"count":0,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/pages\/223\/revisions"}],"wp:attachment":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/media?parent=223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}